Caxton Associates LP Nevro Corp Transaction History

Caxton Associates LP

  • $2.65 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$14.18 - $22.31 $268,994 - $423,220
18,970 New
18,970 $408,000
Q1 2020

May 15, 2020
SELL
$70.23 - $144.31 $177,260 - $364,238
-2,524 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$76.41 - $117.54 $192,858 - $296,670
2,524 New
2,524 $297,000

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email